We are named among the leading manufacturers and exporters of Bortezomib Injection. We formulate the drugs with the help of our highly skilled workforce using quality grade compounds, sourced from the most reliable vendors. The clients can avail our drugs in different quantity packaging options. To provide a flawless range to the clients, we check the Bortezomib Injection on certain quality parameters to ensure that only defect free range is provided to the clients at the cost effective prices.
Long shelf life
- Multiple myeloma
- Mantle cell lymphoma
Dosage in Previously Untreated Multiple Myeloma.
EGYBORT (bortezomib) is administered as a 3-5 second bolus IV injection in combination with oral melphalan and oral prednisone for nine 6-week treatment cycles as shown in Table 1. In Cycles 1-4, EGYBORT is administered twice weekly (days 1, 4, 8, 11, 22, 25, 29 and 32). In Cycles 5-9, EGYBORT is administered once weekly (days 1, 8, 22 and 29). At least 72 hours should elapse between consecutive doses of EGYBORT.
Packing: 1 Vial of 2mg
We also deals in:
|Name of the Product||Composition|
|Egybort 2mg Injection||Bortezomib 2mg|
|Egybort 3.5mg Injection||Bortezomib 3.5mg|
FC/B-1 (Extn.), Mohan Co-operative Industrial Estate, Mathura Road, New Delhi, Delhi, 110044, India